These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28731167)

  • 1. High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
    Zeng SX; Cai QC; Guo CH; Zhi LQ; Dai X; Zhang DF; Ma W
    Oncol Rep; 2017 Sep; 38(3):1645-1654. PubMed ID: 28731167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
    Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
    Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
    Xu J; Li Z; Su Q; Zhao J; Ma J
    Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.
    Jiang T; Tang HM; Lu S; Yan DW; Yang YX; Peng ZH
    Med Oncol; 2013 Dec; 30(4):715. PubMed ID: 24078150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM29 suppresses TWIST1 and invasive breast cancer behavior.
    Ai L; Kim WJ; Alpay M; Tang M; Pardo CE; Hatakeyama S; May WS; Kladde MP; Heldermon CD; Siegel EM; Brown KD
    Cancer Res; 2014 Sep; 74(17):4875-87. PubMed ID: 24950909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma.
    Xu N; Wang L; Sun P; Xu S; Fu S; Sun Z
    Pathol Oncol Res; 2019 Jul; 25(3):875-881. PubMed ID: 29177569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma.
    Zhang J; Ju C; Zhang W; Xie L
    IUBMB Life; 2018 Nov; 70(11):1115-1121. PubMed ID: 30120876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.
    Zhang F; Huang W; Sheng M; Liu T
    Tumour Biol; 2015 Mar; 36(3):2041-8. PubMed ID: 25391425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
    Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
    Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
    Wang G; Shen N; Cheng L; Lin J; Li K
    Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.
    Guo X; Zhang J; Pang J; He S; Li G; Chong Y; Li C; Jiao Z; Zhang S; Shao M
    Tumour Biol; 2016 Jul; 37(7):9181-7. PubMed ID: 26768615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
    Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
    Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
    Sun W; Wang W; Lei J; Li H; Wu Y
    Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of carboxypeptidase X M14 family member 2 predicts an unfavorable prognosis and promotes proliferation and migration of osteosarcoma.
    Zhao X; Li R; Wang Q; Wu M; Wang Y
    Diagn Pathol; 2019 Oct; 14(1):118. PubMed ID: 31651348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
    Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin.
    Xu W; Chen B; Ke D; Chen X
    Aging (Albany NY); 2020 Jul; 12(13):13488-13501. PubMed ID: 32640423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.